Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
VRDN | Viridian Therapeutics | -$1.02 | — | — | — | $72.00K | — | — | — | 08/07/2025 | Get Alert |
VRDN | Viridian Therapeutics | -$0.79 | -$0.96 | -$0.87 | 9.38% | $72.00K | $44.08K | $72.00K | 63.34% | 05/06/2025 | Get Alert |
VRDN | Viridian Therapeutics | -$0.97 | -$1.00 | -$0.81 | 19.00% | $72.00K | $48.77K | $72.00K | 47.63% | 02/27/2025 | Get Alert |
VRDN | Viridian Therapeutics | -$1.09 | -$1.05 | -$1.15 | -9.52% | $72.00K | $40.00K | $86.00K | 115.00% | 11/12/2024 | Get Alert |
VRDN | Viridian Therapeutics | -$1.27 | -$0.89 | -$1.02 | -14.61% | $72.00K | $90.00K | $72.00K | -20.00% | 08/08/2024 | Get Alert |
VRDN | Viridian Therapeutics | -$1.61 | -$1.10 | -$0.79 | 28.18% | $98.00K | $70.00K | $72.00K | 2.86% | 05/08/2024 | Get Alert |
VRDN | Viridian Therapeutics | -$1.13 | -$1.00 | -$1.35 | -35.00% | $105.00K | — | $72.00K | — | 02/27/2024 | Get Alert |
VRDN | Viridian Therapeutics | -$0.86 | -$1.24 | -$1.09 | 12.10% | $1.20M | $110.00K | $72.00K | -34.55% | 11/13/2023 | Get Alert |
VRDN | Viridian Therapeutics | -$1.06 | -$1.29 | -$1.27 | 1.55% | $256.00K | $220.00K | $72.00K | -67.27% | 08/08/2023 | Get Alert |
VRDN | Viridian Therapeutics | -$0.98 | -$1.02 | -$1.61 | -57.84% | $216.00K | $110.00K | $98.00K | -10.91% | 05/09/2023 | Get Alert |
VRDN | Viridian Therapeutics | -$1.32 | -$0.73 | -$1.13 | -54.79% | $214.00K | $510.00K | $105.00K | -79.41% | 03/08/2023 | Get Alert |
VRDN | Viridian Therapeutics | -$1.25 | -$0.95 | -$0.86 | 9.47% | $208.00K | $260.00K | $1.20M | 359.62% | 11/14/2022 | Get Alert |
VRDN | Viridian Therapeutics | -$2.21 | -$0.90 | -$1.06 | -17.78% | $1.09M | $230.00K | $256.00K | 11.30% | 08/15/2022 | Get Alert |
VRDN | Viridian Therapeutics | -$2.91 | -$1.08 | -$0.98 | 9.26% | $1.45M | $300.00K | $216.00K | -28.00% | 05/12/2022 | Get Alert |
VRDN | Viridian Therapeutics | -$5.31 | -$0.90 | -$1.32 | -46.67% | $54.00K | $290.00K | $214.00K | -26.21% | 03/10/2022 | Get Alert |
VRDN | Viridian Therapeutics | -$1.48 | -$1.47 | -$1.25 | 14.97% | $0.00 | $450.00K | $208.00K | -53.78% | 11/04/2021 | Get Alert |
VRDN | Viridian Therapeutics | -$1.82 | -$1.52 | -$2.21 | -45.39% | $168.00K | — | $1.09M | — | 08/11/2021 | Get Alert |
VRDN | Viridian Therapeutics | -$2.65 | -$0.76 | -$2.91 | -282.89% | $828.00K | — | $1.45M | — | 05/06/2021 | Get Alert |
VRDN | Viridian Therapeutics | -$0.31 | -$0.61 | -$5.31 | -770.49% | $880.00K | $80.00K | $54.00K | -32.50% | 03/25/2021 | Get Alert |
VRDN | Viridian Therapeutics | -$0.36 | -$0.13 | -$0.10 | 23.08% | $695.00K | $150.00K | $0.00 | -100.00% | 11/10/2020 | Get Alert |
VRDN | Viridian Therapeutics | -$0.29 | -$0.16 | -$0.12 | 25.00% | $2.51M | $520.00K | $168.00K | -67.69% | 08/05/2020 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q1 | 2025-05-06 | $-0.87 | $-0.96 | 9.38 % |
Q4 | 2025-02-27 | $-0.81 | $-1.00 | 19.0 % |
Q3 | 2024-11-12 | $-1.15 | $-1.05 | -9.52 % |
Q2 | 2024-08-08 | $-1.02 | $-0.89 | -14.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2025-05-06 | $72.00K | $44.08K | 63.3 % |
Q4 | 2025-02-27 | $72.00K | $48.77K | 47.6 % |
Q3 | 2024-11-12 | $86.00K | $40.00K | 115.0 % |
Q2 | 2024-08-08 | $72.00K | $90.00K | -20.0 % |
Viridian Therapeutics (VRDN) is scheduled to report earnings on August 7, 2025. The last reported earnings were for reported on May 6, 2025 for Q1.
The Actual EPS was $-0.87, which beat the estimate of $-0.96.
The Actual Revenue was $72K, which beat the estimate of $44.1K.
Browse earnings estimates, EPS, and revenue on all stocks.